Coronavirus vaccine developer CureVac raises $213 million in IPO - source - Reuters India

6:40pm PDT - August 13th, 2020    stock-market - Reuters

CureVac BV raised $213 million in its initial public offering on Thursday, a person familiar with the matter said, setting the stage for the first stock market debut of a company developing a promising vaccine to combat the novel coronavirus.